Alzprotect

📍 Loos, France🗓 Founded 2007👥 8 employees💰 Last funded Dec 2014
Pharmaceuticals🌐 alzprotect.com
Website LinkedIn
AlzProtect is a biopharmaceutical company that selects leads and develops drug candidates in the field of Neurodegeneration, focusing on Tauopathies. It was Founded by Dr André Delacourte and Pr Patricia Melnyk. The company develops new classes of compounds with novel MOA to bring effective solutions in treating neurodegenerative diseases such as AD, PSP and FTD. AZP2006, the lead product in clinical Phase, has shown robust data and proof of principle in animal studies together with a good safety profile.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Alzprotect?
Alzprotect has 1 investor on record on gritt.io and 1 late-stage investors.
When did Alzprotect last raise funding?
The most recent investment in Alzprotect recorded on gritt.io was in December 2014.
When was Alzprotect founded?
Alzprotect was founded in 2007.
What industry is Alzprotect in?
Alzprotect operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Alzprotect based?
Alzprotect is headquartered in Loos, France.